| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |